Akebia Therapeutics Inc.
AKBA
NSD
Sector: Healthcare
Industry: Biotechnology
0.40
USD
-0.02
(-4.11%)
Optionable: Yes Market Cap: 74 M 90-day average vol: 10,223,940
Previous close: 0.4157 Open: 0.415 Bid: 0.4045 Ask: 0.4045
52 week range
0.30 3.35
Last updated: Friday 12th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Chart
News
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance 3/2/2022
Akebia Therapeutics (AKBA) Reports Q4 Loss, Tops Revenue Estimates
Yahoo Finance 3/1/2022
Akebia GAAP EPS of -$0.40 misses by $0.09, revenue of $59.61M beats by $7.84M
Seeking Alpha 3/1/2022
Akebia Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Business Highlights
Yahoo Finance 3/1/2022
7 Speculative Penny Stocks Worth a Roll of the Dice
Yahoo Finance 2/25/2022
Akebia amends license agreement with Vifor for potential launch of kidney drug
Seeking Alpha 2/22/2022
Akebia Therapeutics Announces Amendment of License Agreement with Vifor Pharma in Preparation for Potential Vadadustat Launch
Yahoo Finance 2/22/2022
Akebia Therapeutics to Report Fourth Quarter and Full-Year 2021 Financial Results and Discuss Recent Business Highlights
Yahoo Finance 2/9/2022
Top Biotech Stocks for Q1 2022
Yahoo Finance 1/18/2022
Akebia Therapeutics to Present at H.C. Wainwright Bioconnect Conference
Yahoo Finance 1/10/2022
Akebia Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference
Yahoo Finance 1/4/2022
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Akebia Therapeutics, Inc. (AKBA) Investigation
Yahoo Finance 12/29/2021
Are Options Traders Betting on a Big Move in Akebia (AKBA) Stock?
Yahoo Finance 12/28/2021
Akebia Therapeutics Announces Participation in Upcoming Investor Conferences
Yahoo Finance 11/24/2021
Akebia Therapeutics to Present at Jefferies London Healthcare Conference
Yahoo Finance 11/15/2021
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!